Category: G21 - Secondary parkinsonism

 Chapter Notes

 G21

Secondary parkinsonism

Huntington's disease (G10)

neurocognitive disorder with Lewy bodies (G31.83)

Shy-Drager syndrome (G90.3)

syphilitic Parkinsonism (A52.19)

 G21.0

Malignant neuroleptic syndrome

Use additional code for adverse effect, if applicable, to identify drug (T43.3X5, T43.4X5, T43.505, T43.595)

neuroleptic induced parkinsonism (G21.11)

 G21.1

Other drug-induced secondary parkinsonism

 G21.11

Neuroleptic induced parkinsonism

Use additional code for adverse effect, if applicable, to identify drug (T43.3X5, T43.4X5, T43.505, T43.595)

malignant neuroleptic syndrome (G21.0)

 G21.19

Other drug induced secondary parkinsonism

Other medication-induced parkinsonism

Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

 G21.2

Secondary parkinsonism due to other external agents

Code first (T51-T65) to identify external agent

 G21.3

Postencephalitic parkinsonism

 G21.4

Vascular parkinsonism

 G21.8

Other secondary parkinsonism

 G21.9

Secondary parkinsonism, unspecified